Financial & competing interests disclosure
E Harris is a partner in Innovation21 Ltd, providing consultancy, advisory and evaluation services to pharmaceutical/biotechnology companies and government funded agencies. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.